A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection

• Status: Completed
• Trial end date: 2015-10-01

Summary

This is a comparative study of the efficacy and safety of tigecycline to imipenem/cilastatin in hospitalized patients with a complicated intra-abdominal infection.

• Phase: Phase 4

Details

• Lead Sponsor: Pfizer
• Treatments: Cilastatin; Imipenem; Minocycline; Tigecycline